Open Collections will be undergoing maintenance Monday June 8th, 2020 11:00 – 13:00 PT. No downtime is expected, but site performance may be temporarily impacted.

UBC Theses and Dissertations

UBC Theses Logo

UBC Theses and Dissertations

Monoamine involvement in hippocampal self-stimulation Van der Kooy, Derek 1977

Your browser doesn't seem to have a PDF viewer, please download the PDF to view this item.

Item Metadata

Download

Media
831-UBC_1977_A8 V38.pdf [ 2.18MB ]
Metadata
JSON: 831-1.0094133.json
JSON-LD: 831-1.0094133-ld.json
RDF/XML (Pretty): 831-1.0094133-rdf.xml
RDF/JSON: 831-1.0094133-rdf.json
Turtle: 831-1.0094133-turtle.txt
N-Triples: 831-1.0094133-rdf-ntriples.txt
Original Record: 831-1.0094133-source.json
Full Text
831-1.0094133-fulltext.txt
Citation
831-1.0094133.ris

Full Text

MONOAMINE INVOLVEMENT IN HIPPOCAMPAL SELF-STIMULATION DEREK [VAN DER KOOY B.Sc, University of Toronto, 1974 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF ARTS in the Department of Psychology We accept this thesis as comforming to the required standard THE UNIVERSITY OF BRITISH COLUMBIA by Derek Van Der Kooy, 1977 In presenting this thesis in partial fulfilment of the requirements for an advanced degree at the University of British Columbia, I agree that the Library shall make it freely available for reference and study. I further agree that permission for extensive copying of this thesis for scholarly purposes may be granted by the Head of my Department or by his representatives. It is understood that copying or publication of this thesis for financial gain shall not be allowed without my written permission. Department of The University of British Columbia 2075 Wesbrook Place Vancouver, Canada V6T 1W5 Date i ABSTRACT The roles of the noradrenergic and serotonergic innervations of the hippocampus were investigated with respect to their involvement in the intracranial self-stimulation of this structure. In the fi r s t study, 6-hydroxydopamine-induced lesions of the dorsal tegmental nora-drenergic bundle ascending to the forebrain had no effect on hippocampal self-stimulation in rats. In the second study, intragastric administra-tion of para-chlorophenylalanine decreased hippocampal self-stimulation, suggesting the importance of a serotonin input in maintaining this behavior. Identical para-chlorophenylalanine treatments resulted in temporary depletions of brain serotonin which paralleled the changes in hippocampal self-stimulation. The maximal decreases in both the bio-chemical and behavioral measures occurred at 4 days' post-drug. Inter-pretations of this deficit in hippocampal self-stimulation in terms of gross sensory and/or motor changes were ruled out, as animals with lateral hypothalamic electrodes showed increases in self-stimulation paralleling the post-drug serotonin changes. An intrasessional analysis of the para-chlorophenylalanine-induced behavioral changes revealed that lateral hypothalamic self-stimulation was facilitated mainly during the first hr of the 2 hr test sessions, whereas the depression in hippo-campal self-stimulation occurred primarily in the last hour of the sessions. The differential effects of para-chlorophenylalanine on lateral hypothalamic and hippocampal self-stimulation provide evidence against simple monoamine theories of reinforcement. A. G. Phillips i i TABLE OF CONTENTS Page ABSTRACT i TABLE OF CONTENTS i i LIST OF TABLES i i i LIST OF FIGURES iv ACKNOWLEDGEMENTS v INTRODUCTION 1 METHODS 2 General Procedure 2 Experiment 1 3 Experiment 2 4 Biochemical procedure 4 Behavioral procedure . ; 5 RESULTS 5 Experiment 1 • 5 Biochemical assays 5 ICSS electrode sites 6 Behavioral analysis 6 Experiment 2 6 Biochemical analysis 6 ICSS electrode sites 12 Behavioral analysis. . . 15 Intrasessional ICSS effects of PCPA 19 DISCUSSION 29 Comparison of experimental treatments 29 Nature of the changes in ICSS after PCPA 30 Theories of monoamine involvement in ICSS 33 REFERENCES 38 LIST OF TABLES Effect of bilateral 6-OHDA injections into dorsal tegmental NE bundle on NE levels in ipsilateral hippocampus Effect of intragastrically administered PCPA on 5-HT levels in the hippocampus and hypothalamus 4 days' post-drug iv LIST OF FIGURES Page Figure 1 Photomicrographs depicting electrode placements in 2 hippocampal ICSS animals. . . . 8 - 9 Figure 2 Effects of 6-OHDA lesions of the dorsal tegmental NE bundle or vehicle control injections on hippocampal ICSS 10-11 Figure 3 Effects of intragastrically administered PCPA on whole brain 5-HT levels . 13-14 Figure 4 Effects of intragastrically administered PCPA on hippocampal and LH ICSS 17-18 Figure 5 (A) Effects of intragastrically administered PCPA on one "high ICSS rate" hippocampal subject and one "low ICSS rate" LH subject 20-21 (B) Photomicrograph depicting electrode placement of the hippocampal animal. . . . 22-23 (C) Photomicrograph depicting electrode placement of the LH animal 24-25 Figure 6 Intrasessional analysis of ICSS responding on day 4 post-PCPA in LH and hippocampal animals 26-27 V ACKNOWLEDGEMENTS The author thanks A. G. Phillips, H. C. Fibiger, F. G. Le Piane, B. B. Gorzalka, S. Atmadja and B. Richter for their help. 1 Experimentation on the neurochemical substrates of reinforce-ment has emphasized monoaminergic mechanism ' . Until recently most studies of intracranial self-stimulation (ICSS) have employed electrode placements in the medial forebrain bundle. However, in attempts to factor out the involvement of norepinephrine (NE), dopamine (DA) and serotonin (5-HT) in ICSS, many studies now use electrode placements specifically in the cell body or terminal regions of one of these monoa-mine systems. Some of these studies have been particularly enlightening, as they have demonstrated that manipulation of a particular monoamine system may have effects on ICSS that are specific to the locus of the electrical stimulation. For example, ipsilateral 6-hydroxydopamine (6-0HDA)-induced lesions of the nigro-neostriatal DA system produce a 31 depression of ICSS at sites in a DA terminal area, the caudate nucleus , but leave ICSS of the DA cell body in the substantia nigra relatively 8 unaffected . Somewhat similarly, intragastric administration of para-chlorophenylalanine (PCPA), a drug which inhibits the biosynthesis of 21 5-HT , decreases ICSS in the caudate but increases ICSS in the lateral 32 hypothalamus . One area in the brain containing monoamine terminals which has been l i t t l e studied in relation to ICSS is the hippocampus. ICSS 49 in the hippocampus has been previously demonstrated and thus motiva-tional functions must be added to the myriad of other behavioral 4 functions in which the hippocampus has been implicated . The unique monoamine innervation of the hippocampus makes it an ideal locus in which to study monoamine involvement in ICSS. Both NE and 5-HT are 28 found in significant amounts in the hippocampus , however, the DA content of the hippocampus is within the range expected for a precursor 13 of NE in NE-producting neurons . The NE innervation of the hippocampus 28 35 41 appears to arise entirely from the locus coeruleus ' * , whereas the 11 20 29 5-HT innervation comes primarily from the median raphe nucleus ' ' . The 5-HT innervation of the hippocampus overlaps the NE innervation in 28 its terminal distribution . Moreover, when iontophoretical ly applied 44 43 both NE and 5-HT inhibit the firing of hippocampal pyramidal cells. The present experiments, then, were designed to investigate the involve-ment in hippocampal ICSS of these topographically similar NE and 5-HT innervations. In a preliminary study i t was shown that 6-0HDA induced deple-34 tions of hippocampal NE did not significantly affect hippocampal ICSS . However, in that study animals were run only in 15 min test sessions, and i t has recently been suggested that test sessions of longer duration might be more likely to reveal ICSS deficits after monoamine manipula-25 tions . In order to investigate this possibility the fi r s t experiment of the present study employed 2 hr test sessions in investigating hippo-campal ICSS after NE depletion. The second experiment compared hippo-campal ICSS to ICSS in a lateral hypothalamic (LH) control group, after depletions of 5-HT with intragastrically administered PCPA. METHODS General procedure: Subjects were male Wistar rats weighing 280-320 g at the time of surgery. Animals were anesthetized with sodium pentobarbital, placed in a Kopf sterotaxic apparatus, and small diameter bipolar nichrome electrodes (Plastic Products Co. MS 303-0, .005 in.) were chronically implanted according to standard procedures. The coordinates for the hippocampal placements were AP 1.6 mm posterior to bregma, L + 3.0 mm, 3 and DV 3.8 mm below dura, with the mouthbar 5.0 mm above the interaural line, and for the LH placements AP-3.2 mm, L + 1.5 mm, and DV-8.6 mm, with the mouthbar 4.2 mm below the interaural line. Electrodes were aimed at the lateral part of the dorsal hippocampus in the CA3 zone as 34 49 previous research ' has shown this area to be most supportive of ICSS. Following recovery from surgery, animals were tested for ICSS in 5 identical plexiglass chambers (46 cm x 30 cm x 24 cm). Depression of a small 2.5 cm wide bar activated an AC constant current stimulator which delivered a variable intensity (1-150 yA) 60 HZ sine wave stimulus of fixed duration (0.2 sec) through a flexible cable, to the chronic electrode assembly. Animals were shaped to the lever for 30 min/day until the response was acquired. After 7 days rats not reaching a c r i -terion of 200 bar-presses/2 hr were rejected from the experiment. Stimu-lation intensities were individually adjusted to el i c i t optimal rates. Prior to experimental treatments all animals received 2 hr test sessions, on alternate days, until ICSS rates had stabilized. Experiment 1: Effects of NE depletion on hippocampal ICSS Thirteen hippocampal ICSS animals were included in the fir s t experiment. After ICSS responding had stabilized 9 animals were pre-pared for intracranial injections of 6-OHDA hydrobromide (4 yg/2 yl , dosage expressed as the base), and 4 control animals received vehicle injections. The 6-OHDA was dissolved in a 0.15 M saline vehicle which contained 0.2 mg/ml ascorbic acid, and was injected intracerebrally at a rate of 0.4 yl/min. Lesions were made bilaterally, after acute inser-tions of a fine 34-gauge cannula into the mesencephalic trajectory of the dorsal tegmental NE bundle. Coordinates were AP + 2.5 mm, L + 1.1 mm, and DV + 3.7 mm from stereotaxic zero (Kopf) with the mouthbar - 4.2 mm 4 below the interaural line. Testing (2 hr ICSS sessions) was resumed on the second day post-lesion and continued on alternate days until day 16 post-lesion. At the termination of testing the animals were sacrificed by cervical fracture, their brains removed, dissected on ice, and NE was 24 measured in the ipsilateral hippocampus . Experiment 2: Effects of PCPA on brain 5-HT, hippocampal ICSS and LH ICSS.  Biochemical procedure: Previous studies of the effects of PCPA on brain 5-HT have 21 26 employed the intraperitoneal route of drug administration ' . In an attempt to minimize the non-specific peripheral effects of PCPA injec-tions which can be problematic in the interpretation of behavioral 48 experiments , we utilized the intragastric route of drug administration. To determine the effects of intragastric PCPA on brain 5-HT, 36 rats were studied independently of the ICSS portion of the experiment. Twenty-four animals were placed under light ether anesthesia and then intubated with a 400 mg/kg dose of PCPA, as a suspension in H2O . On each of days 2, 3, 4, 6, 9 and 12 after PCPA treatment, 4 PCPA and 2 control rats were sacrificed by cervical fracture, their brains removed and 5-HT 52 content of the whole brain determined by biochemical assay . Four additional rats were treated with PCPA in the manner described above, to further determine i f the PCPA-induced depletions of 5-HT were evenly distributed in the brain areas to be studied in the behavioral portion of this experiment. On day 4 post-drug, 5-HT content was measured in both the hippocampus and hypothalamus of the 4 experi-mental rats and compared to values obtained from 4 control animals. 5 Behavioral procedure: Ten animals with hippocampal electrodes and seven animals with lateral hypothalamic electrodes were employed in the second ICSS experi-ment. After ICSS responding had stabilized all animals were intubated with PCPA (400 mg/kg) in an identical manner to- the rats prepared for biochemical analysis in the first portion of this experiment. Two hr ICSS test sessions resumed on the second post-drug day and continued on alternate days until day 10 post-PCPA. It has been shown that the depressive effect of PCPA on median raphe ICSS is differentially distributed within a 2 hr test session, 25 with the largest effect occurring towards the end of the session . For this reason measures of bar-press responding during each 30 min period of the test sessions were obtained for all animals. At the completion of the experiment, subjects were asphyxiated with CO2, their brains rapidly removed and stored in 10% formalin. Brains we're frozen-, sectioned at 40y and sections containing electrode tracts were mounted and stained with Luxol fast blue and counterstained with cresyl violet. RESULTS Experiment 1: Effects of NE depletion on hippocampal ICSS  Biochemical assays: The effect of bilateral mesencephalic injections of 6-OHDA on the levels of NE in the hippocampus ipsilateral to the stimulating electrode are summarized in Table I. The mean level of hippocampal NE in the lesioned group was 3.36% of that in the vehicle.injected control group. All 9 lesioned animals had NE levels that were less than 6.0% of the control group level. The assay technique used is sensitive to 2 ng. 6 ICSS electrode sites: Histological examination of electrode placements was foregone in favor of the biochemical analysis in the present experiment. However, other animals prepared in the identical manner for inclusion in the second ICSS experiment, were shown to have electrodes terminating in the hippocampal formation.- Examples of 2 such placements are shown in Fig. 1. Behavioral analysis: The results of this experiment clearly show that the NE inner-vation of the hippocampus is not necessary for the maintenance of ICSS in this structure. As seen in Fig. 2, ICSS continued at rates comparable to those seen prior to the experimental treatment, both in the group with severe depletions of hippocampal NE induced by 6-OHDA and in the vehicle control group. An analysis of variance indicated an insignificant main effect of groups [F(l,ll) = 1.06, p > .20]. The present experiment, employing 2 hr test sessions, confirms 34 a preliminary report demonstrating a failure to affect short duration sessions (15 min/day) of hippocampal ICSS through NE denervation of the hippocampus. As such, i t shows that even the utilization of long dura-tion ICSS test sessions, as a more sensitive measure of behavioral 8 25 deficits after monoamine manipulations ' , does not provide evidence for NE involvement in hippocampal ICSS. Alternate substrates of hippo-campal ICSS must be considered. Experiment 2: Effects of PCPA on brain 5-HT, hippocampal ICSS and LH ICSS.  Biochemical analysis: The present experiment appears to be the first report of brain 5-HT levels after PCPA administered via the intragastric route. Fig. 3 shows the profound effect of intragastric PCPA (400 mg/kg) on whole 7 TABLE I. Effect of bilateral 6-OHDA injections into dorsal tegmental NE bundle on NE levels in ipsilateral hippocampus. G r o u N ipsilateral hippocampal % of vehicle NE (yg/g) control Vehicle control 4 .358 ± .022 6-OHDA 9 .011 ± .001 3.3 Data represent means [± S.E.M.) i 8 Figure 1 Photomicrographs depicting electrode placements in 2 hippocampal ICSS animals. 9 Figure 2 Effects of 6-OHDA lesions {°~°) of the dorsal tegmental NE bundle or vehicle control injections on hippocampal ICSS. Data represent means (± S.E.M.). 1500 co 1300 JO CO LU CO CO LU cc CL DC < CD 1100 900 700 500 -1 2 4 6 8 10 12 14 16 DAYS A F T E R 6 -OHDA L E S I O N S 12 brain 5-HT levels. Depletions of 5-HT are greatest, down to 20% of control, on day 4 post-PCPA and recover to baseline levels by day 12 post-PCPA. In Fig. 3, each of the mean 5-HT levels on the days after PCPA is expressed as a percentage of the 5-HT levels of control animals sacrificed on that same day. The mean whole brain 5-HT level for all the control animals (n = 12) was .585 yg/gm. Statistical analysis of the data was obviated in view of the lack of overlap between days in the biochemistry of the individual animals, either during the depletion or during the recovery of 5-HT levels. The time course of 5-HT depletion and recovery reported here for intragastric intubation of 5-HT is very similar to that found after 21 ?f> intraperitoneal injections of comparable doses of PCPA ' . However, the intragastric route of administration of PCPA may be a more appro-priate method for depleting 5-HT in behavioral experiments, as peritoneal irritation may result from the intraperitoneal injection of a-methyl-48 tryrosme, PCPA and other insoluble compounds . PCPA treatment depletes 5-HT to a comparable degree in the hippocampus and hypothalamus, as shown in Table II. Thus, on day 4 post-PCPA, both of the areas employed as ICSS electrode sites in the behav-ioral portion of this experiment, show 5-HT levels that are approximately 20% of control. ICSS electrode sites: The histology for 5 hippocampal ICSS animals was unavailable. However, the remaining hippocampal ICSS animals and all the LH ICSS animals had electrodes terminating in the hippocampal formation and lateral hypothalamic area, respectively. Examples of 3 hippocampal ICSS placements from the present experiment are shown in Fig. 1 and Fig. 5 (C). 13 Figure 3 Effects of intragastrically administered PCPA (400 mg/kg) on whole brain 5-HT levels. Data represent means (± S.E.M.). 5-HT L E V E L S (% OF CONTROL ) r\j 4^ O) oo o f\j o o o o o o —i : i i ~\ : — i r 17 L 15 Typically, ICSS placements in the hippocampal formation occur in the anterior portion of the dorsal hippocampus. Most placements are lateral to the dentate gyrus in the CA3 pyramidal zone, with some positive placements extending even farther laterally into the fimbria. Our ICSS placements generally correspond to the previous description of ICSS in 49 the hippocampus . The histology from 1 representative LH ICSS animal in the pre-sent experiment is shown in Fig. 5 (B). All LH ICSS animals had elec-trodes terminating in this same area of the hypothalamus lateral to the fornix, although some placements were situated more dorsally in the LH. Behavioral analysis: As may be seen in Fig. 4, treatment with PCPA produced either a facilitation or depression of ICSS, depending on electrode placement. Hippocampal ICSS animals showed decreased responding for several days after PCPA and LH ICSS animals showed increased responding over the same time period. Both groups returned to baseline rates by day 10 post-PCPA. The time courses for the effects in both groups, peaking at day 4 post-drug, are almost identical to the time course for whole brain 5-HT depletion after intragastric PCPA (Fig. 3). An analysis of variance performed on the raw data revealed a significant effect of groups f_F(l,15) = 21.49, p < .001], which reflected, in part; the different baseline ICSS rates in the LH( "X = 5678/2hr) and hippocampal (X = 1083/2hr) groups. The main effect of PCPA over time was not significant £F(1,15) = 0.62, p > .20], as the opposite effects of the drug in the two groups counteracted each other. However, the effect of the groups X PCPA interaction was significant [F(l,15)' = 5.53, p < .05]. A trend analysis of the groups X PCPA interaction revealed a significant quadratic effect [F (1,15) = 20.88, p < .001], reflecting the reciprocal TABLE II. Effect of intragastrically administered PCPA on 5-HT levels in the hippocampus and hypothalamus 4 days' post-drug. R „ N „ N M Hippocampus Hypothalamus G r 0 U P 5-HT (ug/g) 5-HT (ug/g) Control 4 0.665 ± .01 1.46 ± 0.04 PCPA 4 0.132 ± .07 0.35 ± 0.02 % of control 19.8 24.0 Data represent means (± S.E.M.) Figure 4 Effects of intragastrically administered PCPA (400 mg/kg) on hippo-campal (°-o) and LH (•-•) ICSS. Data represent means (± S.E.M.). 19 changes in the rates of the two groups for several days post-PCPA, and then the return to baseline rates by day 10 after the drug in both groups. Both LH and hippocampal animals were tested at near-optimal ICSS rates. For this reason the increase in LH ICSS after PCPA (110% of baseline on day 4 post-drug) was necessarily•limited to a small effect, and not one as dramatic as that seen when LH animals are tested 32 at below optimal rates . However, the increase in LH ICSS on day 4 post-PCPA was observed in all 7 LH animals compared to their individual rates on the day prior to the drug. The substantially different baseline ICSS rates of the LH and hippocampal groups cannot explain the effects of PCPA seen in the present experiment. As mentioned previously, LH ICSS animals tested at 32 less than optimal rates s t i l l show increases in ICSS after PCPA . In addition, raphe ICSS animals tested at rates comparable to those of the LH group in the present experiment, show a depression in ICSS after 25 PCPA (van der Kooy, Fibiger and Phillips, unpublished observations). Further evidence that the differential effects of PCPA are not attri-butable to rate differences comes from the individual data of some LH and hippocampal animals whose ICSS rates were similar. Fig. 5 presents the behavioral data and histology of a LH animal with lower than average ICSS rates and a hippocampal animal with higher than average ICSS rates. The depressive effect of PCPA on hippocampal ICSS and facilitative effect of PCPA on LH ICSS are clearly evident. Intrasessional ICSS effects of PCPA: The effects of PCPA on ICSS are not evenly distributed throughout the 2 hr test sessions. Fig. 6 shows the change in ICSS during each 30 min period within the 2 hr test session on day 4 post-Figure 5 (A) Effects of intragastrically administered PCPA (400 mg/kg) on one "high ICSS rate" hippocampal subject and one "low ICSS rate" LH subject («>-«•). BAR P R E S S E S / 2 hrs. L2 22 Figure 5 (B) Photomicrograph depicting electrode placement of the "high ICSS rate" hippocampal animal. 23 24 Figure 5 (C) Photomicrograph depicting electrode placement of the "low ICSS rate' LH animal. 25 26 Figure 6 Intrasessional analysis of ICSS responding on day 4 post-PCPA in LH (open bars) and hippocampal (filled bars) animals. Data represent means (± S.E.M.) for each of the four 30 min periods comprising the 2 hr test sessions, expressed as a % of the rates obtained on the day prior to PCPA. * indicates a significant difference from control. I C S S RATE/30 MIN. (% OF PRE -DRUG) LZ 28 PCPA, as a percentage of each comparable 30 min period on the baseline day prior to PCPA. In both groups there is a decline in ICSS rates as the session progresses. The analysis of variance performed on the raw data revealed a significant main effect of intrasessional periods (f (1,15) = 15.70, p < .0l]. A trend analysis on the intrasessional periods showed a significant linear effectjf (1,15) = 25.24, p < .00f], reflecting the decrease in rates from the first 30 min period through to the last of the four 30 min periods. There was, however, a substantial difference between groups on day 4 post-PCPA in the manner in which ICSS rates decreased across periods. The LH group showed ICSS rates higher than baseline during the first two 30 min periods, which then decreased to baseline rates over the last two 30 min periods. In contrast, the hippocampal group showed decreased ICSS rates during the first 30 min period, which then decreased even further over the next 3 periods. These differences in responding between the individual 30 min periods on day 4 post-PCPA (the time of maximal 5-HT depletion) and the periods on the day prior to the drug were analyzed for both groups using planned orthogonal comparisons. After PCPA the LH group showed increases in ICSS rates only during the 0-30 min period (p < .10) and the 30-60 min period (p < .05). The differences from 60-90 min (p > .25) and 90-120 min (p > .25) were not significant. The hippocampal group showed decreases in ICSS rates during all periods: 0.30 min (p < .10), 30-60 (p < .15), 60-90 min (p < .05), and 90-120 min (p < .01). The intrasessional analysis of the present experiment has shown that PCPA treatment facilitates LH ICSS primarily during the first hour of the sessions and depresses hippocampal ICSS to a greater 29 extent during the second hour of the sessions. It confirms a previous report demonstrating facilitation of short duration test sessions of LH 32 ICSS using PCPA . The linear intrasessional decrease in hippocampal ICSS rates after PCPA is similar in form to that reported for median 25 ' raphe ICSS after PCPA . DISCUSSION  Comparison of experimental treatments: The present experiments demonstrate that decreasing the 5-HT input to the hippocampus suppresses hippocampal ICSS, whereas decreas-ing the NE input has no effect on ICSS in this structure. However, in so studying monoamine involvement in hippocampal ICSS, different methods were used in depriving the hippocampus of its 5-HT and NE input. A permanent 6-OHDA-induced lesion of NE neurons .is very different from a temporary PCPA-induced inhibition of synthesis in 5-HT neurons. Never-theless, i t is difficult to argue that the failure to affect hippocampal ICSS after 6-OHDA-induced lesions reflects a less severe neurochemical manipulation compared to that induced by PCPA treatment. Lesions induced by 6-OHDA decreased NE levels in the hippocampus to 3.3% of control levels, whereas a dose of PCPA that proved behaviorally effect-ive in decreasing hippocampal ICSS resulted in a maximal depletion of 5-HT to only 20% of control levels. Another possible explanation for the failure to affect ICSS after 6-0HDA lesions is the development of post-synaptic supersensitivity which, in combination with the few survivingcatecholamine afferents, may have been sufficient to sustain ICSS in the hippocampus. At present, however, there are no data avail-able to indicate that behavioral compensation can be accomplished by 30 denervation supersensitivity in telencephalic NE sensitive neurons. In fact, recent data showing that neurotoxic lesions identical to those 38 used in this experiment, profoundly influence morphine analgesia would appear to argue against such a compensatory role. The intragastric intubation of PCPA is not without its problems when utilized as a tool for investigating behavioral effects of reduced 5-HT levels. The administration of PCPA also results in the 2 5 3 5 5 fall of NE levels ' and may result in changes in adrenal function , although i t is unlikely that these changes mediate the effects on ICSS observed in the present experiment. The increase in LH ICSS and the decrease in hippocampal rates, as well as the decrease seen in caudate 32 ICSS rates , all follow the time course of 5-HT depletion after PCPA, peaking at day 4 post-drug. Brain NE levels, on the other hand, are reduced for a shorter time span and appear to return to pre-drug base-2 53 line before day 2 post-PCPA ' . PCPA effects on adrenal functioning also show a very short time course, with the increased corticosterone 48 levels returning to control values over several hours post-drug . Nature of the changes in ICSS after PCPA: The increase in LH ICSS and the decrease in hippocampal ICSS after PCPA have been shown here to follow the time course of brain 5-HT depletion produced by the drug. For this reason i t is likely that the ICSS changes are mediated at some level by the changes in 5-HT concen-trations. It is always possible that PCPA may affect some as yet 3 uninvestigated hippocampal transmitter, such as histamine , over a time course similar to 5-HT and thus mediate the changes in ICSS. However, at present no evidence exists to support this or other similar possi-bilities. Furthermore, the differential effects of PCPA on hippocampal 31 and LH ICSS cannot be due to differential effects of the drug on 5-HT levels at the 2 electrode sites. 5-HT appears to be approximately equally depleted in the two areas after PCPA, whether measured bio-chemically (Table II) or by histochemical fluorescence^. The opposite effects of PCPA on LH and hippocampal ICSS have implications for neuroanatomical perspectives on ICSS. Prior to the present study, hippocampal ICSS in general could have been conceived 30 of as a simple facilitation, by way of the fimbria and fornix , of "more primary" reinforcement systems in the lateral hypothalamus. However, the opposite effects of PCPA administration on LH and hippo-campal ICSS suggests at least partial independence of the two ICSS systems. This suggestion is supported by evidence from a lesion study differentiating fornical and LH ICSS^. The depression of hippocampal ICSS cannot be due to any gross sensory and/or motor changes produced by PCPA, as LH ICSS was not depressed after the drug. However, several possible explanations of the results, other than one hypothesizing PCPA-induced modifications of the reinforcing values of the brain stimuli, do exist. Complex inter-23 actions between PCPA and different behaviors elicited by the stimula-tion at LH as compared to hippocampal sites might explain the ICSS effects observed. For instance, PCPA produces changes in a c t i v i t y ^ ' ^ 27 and agressive behavior . If brain stimulation elicits more activity, for example, at LH sites as compared to hippocampal sites, then con-ceivably the PCPA-induced activity changes might differentially interact with the brain stimulation-induced activity at the 2 sites to produce the observed effects oh bar-press responding. However, at present i t is not clear how any of these interactions would produce opposite effects on 32 ICSS in the 2 groups. The problem discussed in the preceding paragraph is a familiar one to researchers studying neurochemical-behavioral relationships. It is the problem of specifying cause-effect mechanisms based on correla-tions between a neurochemical variable and a behavioral variable. In analyzing the present data two possible explanatory mechanisms exist. First, as mentioned above, PCPA-induced changes in the excitability of certain sensory and/or motor mechanisms (for example, locomotor activity) may interact with the behavior elicited differentially at the 2 electrode sites to mediate the ICSS changes observed. Alternatively, the depletion of 5-HT levels after PCPA may directly and differentially alter the reinforcing value of the brain stimulation at the hippocampal and LH sites. These changes in the reinforcing value of the stimula-tion might then mediate the other behavioral changes observed (again for example, locomotor activity); the reinforcement changes might exist independently of the activity changes; or finally, they might actually be the same change i f theories of reinforcement suggesting isomorphism between reinforcement and the activity in neural pathways underlying species-specific behaviors, are correct^'^. The only means of differentiating between these complex interactive explanations is through a more detailed analysis of the behavioral, neurophysiological and neurochemical changes that occur after PCPA. As the description of the changes induced by PCPA at each level becomes more precise, the relationship between the effects at the neurochemical level and those at the behavioral level (and thus the nature of the ICSS effects) should be more easily specifiable. In the present experiment, the intrasessional analysis of 33 the PCPA effects on LH and hippocampus ICSS (Fig. 6) may provide some initial data in the more detailed behavioral characterization of post-drug ICSS changes. At the time of maximal 5-HT depletion (4 days' post-PCPA), the increase in LH ICSS occurs primarily during the first hour of the 2 hr session, whereas the decrease in hippocampus ICSS is maxi-mal during the last hour of the session. A gradual decrease in median raphe ICSS within test sessions after PCPA treatment has been attributed to the progressive disappearance of remaining brain 5-HT, which had been partially maintaining ICSS until the electrical stimulation depleted 5-HT 25 levels even further . However, there is no independent evidence that electrical stimulation further depletes 5-HT levels in neurons previously depleted by PCPA administration. In addition, i t is difficult to relate this further depletion after electrical stimulation to the increase in LH ICSS that occurs during the initial portion of the test sessions. Nevertheless, similar attempts in the future to correlate more discrete behavioral with more subtle biochemical changes after PCPA treatment offer the only solution to characterizing the nature of the ICSS changes observed here. Theories of monoamine involvement in ICSS: Theories of ICSS emphasizing one monoamine system as the neural basis of reinforcement, i f not doomed in principle, have received l i t t l e or no support in recent studies. The discovery that ICSS could be elicited from sites corresponding to the NE cell bodies 15 40 in the locus coeruleus 5 provided initial support for the role of 14 17 46 NE in ICSS ' ' . However, the "NE theory" has not been supported in recent tests of this theory employing specific lesions of central NE pathways. For example, locus coeruleus ICSS survives 6-OHDA-induced 34 9 12 lesions severely depleting forebrain or whole brain NE , and ICSS in 10,22 more anterior brain areas survives lesions of the locus coeruleus 34 In addition, the present results and those of a preliminary study revealed that ICSS.in telencephalic areas is not affected by nearly complete denervation of the NE input to those areas. Furthermore, recent studies have suggested the involvement of other non-catechola-minergic systems in ICSS elicited from the area of the locus coeru-l e u s 4 2 ' 5 1 . Theories of reinforcement emphasizing the action of an 39 56 inhibitory or aversive 5-HT system ' have also not been completely consistent with current research. Studies employing LH ICSS electrode 5 32 36 placements generally show increases in ICSS after PCPA treatment ' 5 (the present results). Similarly, the neurotoxic lesion of 5-HT neurons by intraventricular 5,6-dihydroxytryptamine increases LH 37 ICSS , and the administration of a 5-HT precursor, 5-hydroxytrypto-phan, depresses LH ICSS^. However, the utilization of ICSS electrode placements specifically in 5-HT cell body or terminal areas gives very different results after 5-HT manipulations. ICSS in forebrain areas 32 innervated by 5-HT neurons, such as the caudate and the hippocampus (the present experiment), is suppressed after PCPA treatment. The effects of PCPA on ICSS elicited from sites corresponding to the 5-HT cell bodies appear to depend on electrode placement. Increases in 47 25 dorsal raphe ICSS and decreases in median raphe ICSS have been reported after PCPA. Recent data from our laboratory (van der Kooy, Fibiger and Phillips, unpublished observations) have shown a small suppression of raphe ICSS that is a function of electrode placement, duration of test session and baseline rate of responding. 35 The differential effects on hippocampal and LH ICSS in the present experiments, as well as the literature cited above, clearly show that the effects of PCPA on ICSS are dependent on electrode place-ment. Conceptually similar effects on ICSS occur after the manipulation of central DA systems. 6-OHDA-induced lesions of the nigrostriatal 32 bundle depress ICSS in one area, the caudate , and leave relatively Q unaffected ICSS in another area, the substantia nigra . Neither of these placement dependent series of effects (after either DA or 5-HT manipulations) can be explained by theories of intracranial reinforce-ment that emphasize one transmitter system which "codes" reinforcement functions in the brain. Although theoretically parsimonious, the idea that a single neurotransmitter system subserves reinforcement functions in the brain now seems simplistic. As the present experiments show, a certain neurochemical manipulation may have opposite effect on ICSS depending on electrode site. Moreover, ICSS can be elicited from very diverse 33 brain areas, including primary sensory systems in the olfactory bulb 51 and final motor pathways in the trigeminal nucleus . Therefore, one reason for the correlation between ICSS electrode sites and catechola-mine neurons^ is that both exist almost everywhere in the brain. Future attempts to understand the structural organization of reinforce-ment functions in the brain will have to deal with the ubiquitous nature of ICSS. A single neurochemical reinforcement system should not be expected in the brain, given the variety of neural systems activated by sensory stimuli even in a simple operant reinforcement situation involving bar-press responding. One suspects that the problem of ICSS anatomical organization is not one of simply "more 36 data needs"34, but one of better conceptualization of reinforcement functions. One approach to the results of the present experiment is through the question of necessary versus sufficient neurochemical sub-strates of hippocampal ICSS. The results suggest that the NE inner-vation of the hippocampus is not necessary for hippocampal ICSS, but that the 5-HT input is necessary for the normal maintenance of this behavior. This is not to say that the NE input may not be sufficient to maintain hippocampal ICSS in the absence of other afferents to the hippocampus. However, the NE input may not even be a sufficient con-dition for normal hippocampal ICSS, as the NE afferents failed to maintain hippocampal ICSS, in the present study, after the PCPA-induced reduction in 5-HT input. It may also be the case.that two or more identified inputs to a certain brain structure are necessary for the maintenance of ICSS in that area.. For example; depriving the caudate 32 31 of either its 5-HT or DA inputs depresses caudate ICSS. Further data on the anatomy of hippocampal ICSS might be profitably gained from a study of the necessity of individual efferent fiber systems in the maintenance of hippocampal ICSS. In questioning the importance of a locus coeruleus-hippocampal 45 NE reinforcement pathway and pointing to the necessity of the 5-HT input for hippocampal ICSS, the present experiments should not be con-strued as evidence for a new "5-HT theory" of reinforcement. First, the depressive effect of PCPA administration on ICSS behavior in the present study is specific to the hippocampus, with opposite results occurring in the LH. In addition, the complete neural system necessary for hippocampal ICSS, including intrisic and efferent hippocampal 37 pathways, has not been outlined. It is doubtful that the necessary anatomical substrates of hippocampal ICSS end pre-synaptically in 5-HT afferent terminals. Finally, i t has not been unequivocally demonstrated that the deficit in hippocampal ICSS after PCPA is actually the result of a decrease in the positively reinforcing value of the brain stimula-tion. The nature of this deficit in ICSS is probably the most interest-ing problem for future experimentation. 38 REFERENCES 1. Aghajanian, G. K., Kuhar, M. J. and Roth, R. H., Serotonin-containing neuronal perikarya and terminals: differential effects of p-chlorophenylalanine. Brain Research, 54 (1973) 85-101. 2. Ahlenius, S., Engel, J., Eriksson, H., Modigh, K., and Sodersten, P., Importance of central catecholamines in the mediation of lordosis behavior in overiectomized rats treated with estrogen and inhibitors of monoamine synthesis. J. Neural Trans., 33 (1972), 247-255. 3. Barbin, C, Garbarg, M., Schwartz, J. C, and Storm-Mathisen, J., Histamine synthesizing afferents to the hippocampal region. J. Neurochem. 26 (1976) 259-263. 4. Black, A. H., Hippocampal electrical activity and behavior. In R. L. Isaacson and K. H. Pribran (Eds.). The Hippocampus, Vol. 1, Plenum Press, New York, 1975, pp. 129-168. 5. Blum, K., and Geller, I., Facilitation of brain stimulation with para-chlorophenylalanine. Fed. Proc. 28 (1969; 794. 6. Bose, S., Bailey, P. T., Thoa, N. B., and Pradham, S. N., Effects of 5-hydroxytryptophane on self-stimulation in rats. Psychopharma- cologic 36 (1974) 255-262. 7. Brown, R. J., and Winocur, G., The fornix as a reward pathway, Physiol. Behav. 11 (1973) 47-52. 8. Clavier, R. M., and Fibiger, H. C, On the role of ascending catecholaminergic projections in intracranial self-stimulation of the substantia nigra, submitted for publication. 9. Clavier, R. M., Phillips, A. G., and Fibiger, H. C, Evidence that self-stimulation of the region of the locus coeruleus does not depend upon noradrenergic projections to telencephalon. Brain  Research 113 (1976) 71-81. 39 10. Clavier, R. M., and Routtenberg, A., Brain stem self-stimulation attenuated by lesions of medial forebrain bundle but not by lesions of locus coeruleus or the caudal ventral norepinephrine bundle. Brain Research 101 (1976) 251-271. . 11. Conrad, L. C. A., Leonard, C. M., and Pfaff, D. W., Connections of the median and dorsal raphe nuclei in the rat: an autoradio-graphic and degeneration study. J. Comp. Neurol. 156 (1974) 179-206. 12. Cooper, B. R., and Breese, G. R., A role for dopamine in the psychopharmacology of electrical self-stimulation of the lateral hypothalamus, substantia nigra, and locus coeruleus. In The  Functional Significance of Brain Monoaminergic Systems, Pharmacological and Biochemical Approaches, in press (1976). 13. Costa, E., Green, A. R., Koslow, S. H., LeFevre, H. F., Revuelta, A. V., and Wang, C , Dopamine and norepinephrine in noradrenergic axons: a study in vivo of their precursor product relationship by mass fragmentography and radiochemistry. Pharmac. Rev. 24 (1972) 167-190. 14. Crow, T. J., Catecholamine containing neurons and electrical self-stimulation. 1 A review of some data. Psychol. Med. 2 (1972) 414-421. 15. Crow, T. J., Spear, P. J., and Arbuthnott, G. W., Intracranial self-stimulation with electrodes in the region of the locus coeruleus. Brain Research 36 (1972) 275-287. 16. Fibiger, H. C, and Campbell, B. A., The effect of para-chlorophenylalanine on spontaneous locomotor activity in the rat. Neuropharmacology 10 (1971) 25-32. German, D. C, and Bowden, D. M., Catecholamine systems as the neural substrate for intracranial self-stimulation. Brain  Research 73 (1974) 381-419. Glickman, S. E., and Schiff, B. B., A biological theory of reinforcement. Psychol. Rev. 74 (1967) 81-109. Jacobs, B. L., Trimback, C, Eubanks, E. E., and Trubson, M., Hippocampal mediation of raphe lesion - and PCPA-induced hyperactivity in the rat. Brain Research 94 (1975) 253-262. Jacobs, B. L., Wise, W. D., and Taylor, K. M., Differential behavioral and neurochemical effects following lesions of the dorsal or. median raphe nuclei in rats. Brain Research 79 (1974) 353-361. Koe, B. C, and Weissman, A., P-chlorophenylalanine: A specific depletor of brain serotonin. J. Pharmac. Exp. Ther. 154 (1966) 499-516. Koob, G. F., Balcom, G. J., and Meyerhoff, J. L., Increases in intracranial self-stimulation in the posterior hypothalamus following unilateral lesions in the locus coeruleus. Brain  Research 101 (1976) 554-560. Madryga, F. J., and Albert, D. J., Procaine injections into MFB-LHA during septal and preoptic self-stimulation. Physiol. Behav. 6 (1971) 695-701. McGeer, E. G., and McGeer, P. L., Catecholamine content of the spinal cord. Cand. J. Biochem. Physiol. 40 (1962) 1141-1151. Milliaressis, E., Bouchard, A., and Jacobowitz, D. M., Strong positive reward in median raphe: specific inhibition by para-chlorophenylalanine. Brain Research 98 0975) 194-201. 41 26. Miller, F. P., Cox, R. H., Jr., Snodgrass, W. R., and Maickel, R. P., Comparative effects of p-chlorophenylalanine, p-chloro-amphetamine and p-chloro-n-methylamphetamine on rat brain nore-pinephrine, serotonin and 5-hydroxyindole-2-acetic acid. Biochem. Pharma. 19 (1970) 435-442. 27. Miczek, K. A., Altman, J. L., Appel, J. B., and Boggan, W. 0., Para-chlorophenylalanine, serotonin and killing behavior. Pharmac. Biochem. Behav. 3(1975) 355-361. 28. Moore, R. Y., Monoamine neurons innervating the hippocampal formation and septum: organization and response to injury. In R. L. Isaacson and K. H. Pribram (Eds.). The Hippocampus, Vol. 1, Plenum Press, New York, 1975, pp. 215-238. 29. Moore, R. Y., and Halaris, A. E., Hippocampal innervation by serotonin neurons of the midbrain raphe in the rat. J. Comp. Neurol. 164 (1975) 171-184. 30. Nauta, W. J. H., An experimental study of the fornix system in the rat. J. Comp. Neurol. 104 (1956) 247-272. 31. Phillips, A. 6.,Carter,D. A., and Fibiger, H. C, Dopaminergic substrates of intracranial self-stimulation in the caudate-putamen. Brain Research 104 (1976a) 221-232. 32. Phillips, A. G., Carter, D. A., and Fibiger, H. C, Differential effects of para-chlorophenylalanine on self-stimulation in caudate-putamen and lateral hypothalamus. Psychopharmacology (1976b) in press. 33. Phillips, A. G., and Mogenson, G. J., Self-stimulation of the olfactory bulb. Physiol. Behav. 14 (1969) 195-197. 42 34. Phillips, A. G., van der Kooy, D., and Fibiger, H. C, Maintenance of intracranial self-stimulation in hippocampus and olfactory bulb following regional depletion of noradrenaline, submitted for publication. 35. Pickel, V. M., Segal, M., and Bloom, F. E., A radioautographic study of the efferent pathways of the nucleus locus coeruleus. J. Comp. Neurol. 155 (1974) 15-42. 36. PoscheT, B. P. H., and Ninteman, F. W., Intracranial reward and the forebrain's serotonergic mechanism: studies employing para-chlorophenylalanine and para-chloroamphetamine. Physiol. and  Behav. 7 (1971) 39-46. 37. Poschel, B. P. H., Ninteman, F. W., McLean, J. R., McLean and Potoczak, D., Intracranial reward after 5,6-dihydroxytryptamine: further evidence for serotonin's inhibitory role. Life Sciences 15 (1974) 1515-1522. 38. Price, M. T. C, and Fibiger, H. C, Ascending catecholamine pathways and morphine analgesia. Brain Research 99 (1975) 189-193. 39. Pribram, K. H., and McGuinness, Arousal, activation and effort in the control of attention. Psychol. Rev. 82 (1975) 116-149. 40. Ritter, S., and Stein, L., Self-stimulation of the noradrenergic cell group (A6) in locus coeruleus of rats. J. Comp. Physiol. Psychol. 85 (1973) 443-452. 41. Roberts, D. C. S., Price, M. T. C, and Fibiger, H. C, The dorsal tegmental noradrenergic projection: an analysis of its role in maze learning. J. Comp. Physiol. Psychol. 90 (1976) 363-372. 43 42. Rolls, E. T., and Cooper, S. J., Anaesthetization and stimulation of the sulcal prefrontal cortex and brain stimulation reward. Physiol. Behav. 12 (1974) 563-571. 43. Segal, M., Physiological and pharmacological evidence for a sero-tonergic projection to the hippocampus. Brain Research 94 (1975) 115-131. 44. Segal, M., and Bloom, F. E., The action of norepinephrine in the rat hippocampus, I. Iontophoretic studies. Brain Research 72 (1974) 79-97. 45. Segal, M., and Bloom, F. E., The action of norepinephrine in the rat hippocampus, III. Hippocampal cellular responses to locus coeruleus stimulation in the awake rat. Brain Research 107 (1976) 499-511. 46. Stein, L., Belluzzi, J. D., and Wise, C. D., Norepinephrine self-stimulation pathways: implications for long-term memory and schizophrenia. In A. Wauquier and E. T. Rolls (Eds.). Brain  Stimulation Reward, North-Holland, Amsterdam, 1976, pp. 297-331. 47. Simon, H., LeMoal, M., and Cardo, R., Intracranial self-stimulation from the dorsal raphe nucleus of the rat: effects of the injection of para-chlorophenylalanine and of alpha-methylparatyrosine. Behav. Biol. 16 (1976) 353-364. 48. Thornburg, J. E., and Moore, K. E., Stress-related effects of various inhibitors of catecholamine synthesis in the mouse. Arch, int. Pharmacodyn 194 (1971) 158-167. 49. Ursin, R., Ursin, H., and Olds, J., Self-stimulation of hippo-campus in rats. J. Comp. Physiol. Psychol. 61 (1966) 353-359. 44 50. Valenstein, E. S., Cox, V. C, and Kakolewski, J. W., Re-examination of the role of the hypothalamus in motivation. Psychol. Rev. 77 (1970) 16-31. 51. van der Kooy, D., and Phillips, A. G., Trigeminal involvement in brainstem self-stimulation and stimulation-bound behavior. Neuroscience Abstracts 2 (1976) 454. 52. Wada, J. A., and McGeer, E. G., Central aromatic amines and behavior. Arch. Neurol. 14: (1966) 129-142. 53. Welch, A. S., and Welch, B. L., Effect of p-chlorophenylalanine on brain noradrenaline in mice. J. Pharm. Pharmacol. 19 (1967) 632-633. 54. Wetzel, M. C, Self-stimulations anatomy: data needs. Brain  Research 10 (1968) 287-296. 55. Whalen, R. E., Gorzalka, B. B. and Debold, J. R., Methodological considerations in the study of animal sexual behavior. In M. Sandler and G. L. Gessa (Eds.). Sexual Behavior: Pharmacology  and Biochemistry, Raven Press, New York, 1975, pp. 33-44. 56. Wise, C. D., Berger, B. D., and Stein, L., Evidence of alpha-noradrenergic reward receptors and serotonergic punishment receptors in the rat brain. Biol. Psychiatry 6 (1973) 3-21. 

Cite

Citation Scheme:

        

Citations by CSL (citeproc-js)

Usage Statistics

Share

Embed

Customize your widget with the following options, then copy and paste the code below into the HTML of your page to embed this item in your website.
                        
                            <div id="ubcOpenCollectionsWidgetDisplay">
                            <script id="ubcOpenCollectionsWidget"
                            src="{[{embed.src}]}"
                            data-item="{[{embed.item}]}"
                            data-collection="{[{embed.collection}]}"
                            data-metadata="{[{embed.showMetadata}]}"
                            data-width="{[{embed.width}]}"
                            data-media="{[{embed.selectedMedia}]}"
                            async >
                            </script>
                            </div>
                        
                    
IIIF logo Our image viewer uses the IIIF 2.0 standard. To load this item in other compatible viewers, use this url:
https://iiif.library.ubc.ca/presentation/dsp.831.1-0094133/manifest

Comment

Related Items